Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | 34.44 | -16.76 |
PEG Ratio (TTM) | -5.17 | -5.49 |
P/S Ratio (TTM) | N/A | 37.55 |
P/B Ratio (TTM) | 2.14 | 5.85 |
P/FCF Ratio (TTM) | -220.09 | -149.32 |
Price to 5YR AVG Earnings Ratio | N/A | -33.81 |
Price to 5YR AVG FCF Ratio | N/A | -1.26 |
Profitability (20%) |
Company | Industry |
---|---|---|
ROA (TTM) | 5.10% | 284.70% |
ROE (TTM) | 5.97% | -4,182.30% |
Net Profit Margin (TTM) | N/A | -1,002.59% |
ROIC 5YR AVG | N/A | -16.06% |
Growth (0%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -1.04% | N/A | N/A |
Revenue | N/A | N/A | N/A |
Net Income | -9.41% | N/A | N/A |
Cash Flow | -14,919.56% | N/A | N/A |
Health (39%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 0.01 | 4.92 |
Quick Ratio (TTM) | 0.01 | 4.90 |
D/E Ratio (TTM) | 0.11 | 1.29 |
Interest Coverage (TTM) | -0.43 | -11.14 |
Piotroski F-Score | 3 | 3 |
Altman Z-Score | 6.03 | 20.80 |
LTL to 5YR AVG FCF | N/A | -0.53 |
Shares Outstanding Growth 5YR AVG | N/A | 887.85% |